UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 48

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy

Dementia and geriatric cognitive disorders, 2006-01, Vol.21 (5-6), p.353-363

2006

Volltextzugriff (PDF)

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

Neurology, 2001-08, Vol.57 (3), p.489-495

2001

Volltextzugriff (PDF)

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study

The Lancet (British edition), 2006-04, Vol.367 (9516), p.1057-1065

2006

Volltextzugriff (PDF)

An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial

Dementia and geriatric cognitive disorders, 2003-01, Vol.15 (1), p.44-54

2003

Volltextzugriff (PDF)

P.4.041 Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study

European neuropsychopharmacology, 2003-10, Vol.13, p.S402-S403

2003

Volltextzugriff (PDF)

P.4.044 Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study

European neuropsychopharmacology, 2003-10, Vol.13, p.S404-S404

2003

Volltextzugriff (PDF)

Donepezil improved or stabilized cognition over one year in patients with mild and moderate Alzheimer's disease

European neuropsychopharmacology, 2000-09, Vol.10, p.368-368

2000

Volltextzugriff (PDF)

Efficacy of donepezil on primary end points in a randomized, double-blind placebo-controlled study in severe Alzheimer's disease

INTERNATIONAL PSYCHOGERIATRICS, 2005, Vol.17, p.238

2005

Volltextzugriff (PDF)

Efficacy of donepezil on secondary end points in a randomized, double-blind placebo-controlled study in severe Alzheimer's disease

INTERNATIONAL PSYCHOGERIATRICS, 2005, Vol.17, p.240

2005

Volltextzugriff (PDF)

Study design and baseline patient characteristics in a randomized controlled trial (RCT) of the efficacy and tolerability of donepezil in severe Alzheimer's disease (AD)

INTERNATIONAL PSYCHOGERIATRICS, 2005, Vol.17, p.240

2005

Volltextzugriff (PDF)

Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study

INTERNATIONAL PSYCHOGERIATRICS, 2003, Vol.15, p.292

2003

Volltextzugriff (PDF)

Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study

INTERNATIONAL PSYCHOGERIATRICS, 2003, Vol.15, p.293

2003

Volltextzugriff (PDF)

Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, Vol.13, p.S404

2003

Volltextzugriff (PDF)

Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a-one-year placebo-controlled study and participated in a two-year follow-up study

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, Vol.13, p.S402

2003

Volltextzugriff (PDF)

Long-term benefits of donepezil on ADLs in AD patients

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, Vol.48 (8), p.S107

2000

Volltextzugriff (PDF)

RWMAs in critically ill patients with non‐obstructed coronary arteries

Acta anaesthesiologica Scandinavica, 2023-07, Vol.67 (6), p.746-754

2023

Volltextzugriff (PDF)

Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low

European journal of clinical pharmacology, 2021-09, Vol.77 (9), p.1323-1331

2021

Volltextzugriff (PDF)

Internet delivered Cognitive Behavior Therapy for Antenatal Depression: A Randomised Controlled Trial

Journal of affective disorders, 2017, Vol.221, p.56-64

2017

Volltextzugriff (PDF)

Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease

PloS one, 2012-07, Vol.7 (7), p.e41786-e41786

2012

Volltextzugriff (PDF)

MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero

BMJ open, 2018-08, Vol.8 (8), p.e023281-e023281

2018

Volltextzugriff (PDF)

Kinematics of diving Atlantic puffins (Fratercula arctica L.): evidence for an active upstroke

Journal of experimental biology, 2002-02, Vol.205 (Pt 3), p.371-378

2002

Volltextzugriff (PDF)

Why did the Magdalena study- an RCT on the effects on infants born to women with treatment of depression in pregnant women-fail?

NEUROTOXICOLOGY AND TERATOLOGY, 2022, Vol.92

2022

Volltextzugriff (PDF)

Imaging of Atherosclerosis in WHHL Rabbits Using High-Resolution Ultrasound

Ultrasound in medicine & biology, 2007-05, Vol.33 (5), p.720-726

2007

Volltextzugriff (PDF)

Leukotriene A4 hydrolase: determination of the three zinc-binding ligands by site-directed mutagenesis and zinc analysis

Proceedings of the National Academy of Sciences - PNAS, 1991-09, Vol.88 (17), p.7620-7624

1991

Volltextzugriff (PDF)

Leukotriene A4 hydrolase: abrogation of the peptidase activity by mutation of glutamic acid-296

Proceedings of the National Academy of Sciences - PNAS, 1992-10, Vol.89 (19), p.9141-9145

1992

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(39)
Tagungsberichte
(9)

Sprache

Englisch
(48)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study

An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial

P.4.041 Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study

P.4.044 Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study

Donepezil improved or stabilized cognition over one year in patients with mild and moderate Alzheimer's disease

Efficacy of donepezil on primary end points in a randomized, double-blind placebo-controlled study in severe Alzheimer's disease

Efficacy of donepezil on secondary end points in a randomized, double-blind placebo-controlled study in severe Alzheimer's disease

Study design and baseline patient characteristics in a randomized controlled trial (RCT) of the efficacy and tolerability of donepezil in severe Alzheimer's disease (AD)

Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study

Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study

Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study

Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a-one-year placebo-controlled study and participated in a two-year follow-up study

Long-term benefits of donepezil on ADLs in AD patients

RWMAs in critically ill patients with non‐obstructed coronary arteries

Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low

Internet delivered Cognitive Behavior Therapy for Antenatal Depression: A Randomised Controlled Trial

Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease

MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero

Kinematics of diving Atlantic puffins (Fratercula arctica L.): evidence for an active upstroke

Why did the Magdalena study- an RCT on the effects on infants born to women with treatment of depression in pregnant women-fail?

Imaging of Atherosclerosis in WHHL Rabbits Using High-Resolution Ultrasound

Leukotriene A4 hydrolase: determination of the three zinc-binding ligands by site-directed mutagenesis and zinc analysis

Leukotriene A4 hydrolase: abrogation of the peptidase activity by mutation of glutamic acid-296

Suchergebnisse filtern